Propofol self-micro-emulsifying composition and preparation method thereof

A technology of self-microemulsification and propofol, which is applied to the active ingredients of hydroxyl compounds, drug combinations, drug delivery, etc., can solve the problems of injection pain and low oral bioavailability, to promote absorption, improve oral bioavailability, Good patient compliance

Inactive Publication Date: 2010-03-24
WUXI APPTEC (TIANJIN) CO LTD +3
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to solve the technical problems of injection pain and extremely low oral bioavailability in

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Propofol self-micro-emulsifying composition and preparation method thereof
  • Propofol self-micro-emulsifying composition and preparation method thereof
  • Propofol self-micro-emulsifying composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0025] Example 1

[0026] Proportion: Propofol 10g

[0027] Polyoxyethylene hydrogenated castor oil 40 60g

[0028] Divinyl glycol monoethyl ether 20g

[0029] Isopropyl myristate 10g

[0030] Butyl hydroxyanisole 0.02%

[0031] Preparation method: Weigh an appropriate amount of propofol, add the prescribed amount of oil phase, emulsifier, co-emulsifier and antioxidant, stir and mix to obtain isopropyl at room temperature, protected from light and nitrogen. Phenol self-microemulsifying composition.

Example Embodiment

[0032] Example 2

[0033] Proportion: Propofol 10g

[0034] Polyoxyethylene hydrogenated castor oil 40 56g

[0035] Isopropyl alcohol 19g

[0036] Isopropyl myristate 15g

[0037] Tert-butyl hydroquinone 0.02%

[0038] Preparation method: Weigh an appropriate amount of propofol, add the prescribed amount of oil phase, emulsifier, co-emulsifier and antioxidant, stir and mix to obtain isopropyl at room temperature, protected from light and nitrogen. Phenol self-microemulsifying composition. The prepared self-emulsifying microemulsion composition is prepared into the storage layer of the transdermal patch, which is sequentially compounded with the backing layer and the pressure-sensitive layer on one side, and then compounded with the controlled release layer and the protective layer on the other side. The transdermal patch containing self-emulsifying microemulsion is obtained.

Example Embodiment

[0039] Example 3

[0040] Proportion: Propofol 10g

[0041] Polyoxyethylene castor oil 35 45g

[0042] Isopropyl alcohol 30g

[0043] Ethyl oleate / corn oil (2∶1) 15g

[0044] Butyl hydroxyanisole 0.02%

[0045] Preparation method: Weigh an appropriate amount of propofol, add the prescribed amount of oil phase, emulsifier, co-emulsifier and antioxidant, stir and mix to obtain isopropyl at room temperature, protected from light and nitrogen. Phenol self-microemulsifying composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a propofol self-micro-emulsifying composition and a preparation method thereof, mainly aiming at solving the technical problems of injection pain and extremely low oral bioavailability of the existing fat emulsion. The invention has the technical scheme that the propofol self-micro-emulsifying composition comprises the components by weight percent: 1-15% of propofol, 10-70% of emulsifying agent, 0-50% of auxiliary emulsifying agent and 0-30% of oil phase. The new formulation of propofol has the characteristics of low gastrointestinal metabolism, higher bioavailability,good stability and easy preparation.

Description

technical field [0001] The invention relates to a propofol self-microemulsifying composition and a preparation method thereof. Background technique [0002] Propofol, namely 2,6-diisopropylphenol, is a new type of systemic intravenous anesthetic. It has the advantages of quick onset, short action time, quick and complete recovery, few adverse reactions, no sequelae, wide application range (can be used for anesthesia induction, maintenance and auxiliary epidural anesthesia), and easy-to-control dosage. Therefore, since its anesthetic activity was discovered in 1977, many researches have been carried out on the formulation, and clinical application has been more and more extensive. In recent years, the drug has been widely used in clinical anesthesia induction and anesthesia maintenance, and sedation of intensive care patients. It can be used for intensive monitoring of adult patients receiving mechanical ventilation and sedation during surgery, and can also be used for cons...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/107A61K9/66A61K31/05A61P23/00
Inventor 王高森高萍郭庆海王宇邦
Owner WUXI APPTEC (TIANJIN) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products